This manuscript outlines the difficulties of providing safe thoracic surgery during COVID-19 and details solutions for overcoming these challenges.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung
Prognostic Factors Related to Postoperative Survival in the Newly Classified Clinical T4 Lung Cancer
April 21, 2020
This manuscript by Yamanashi et al retrospectively looks into the outcome of patients with newly classified clinical T4 lung cancer. They report 93 patients who underwent surgical treatment during a 10-year study period.
April 12, 2020
This video demonstrates a video-assisted thoracoscopic approach for left lung upper lobe anterior segment GGO.
April 10, 2020
The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC. Survival was better in patients who underwent surgery in a short delay interval (<77 days) compared to a long delay (>114 days); short and medium delay intervals had similar outcomes.
March 24, 2020
A succinct comment with a wealth of up-to-date references vis-a-vis the SARS-CoV-2 pandemic.
March 23, 2020
This case report suggests that recurrent right pleural effusions could be a side effect of hepatic artery infusion pump chemotherapy in the treatment of metastatic colorectal cancer.
March 22, 2020
Leanne Harling, Doug Mathisen, and Erino Rendina share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.
March 20, 2020
Interesting input from a Stanford expert on the hottest topic on the planet at the moment.
March 18, 2020
The authors describe a thoughtful process for resource utilization in the setting of competing needs that optimizes survival for a popultion. Examples of existing guidelines are provided.
March 18, 2020
The authors examined the SEER database to assess racial disparities in use of PET for lung cancer staging 2007-2015 and subsequent one-year survival. Blacks (OR 0.54) and Hispanics (OR 0.72) were less likely to undergo PET compared to non-Hispanic whites. Use of PET was associated with improved survival (HR 0.61).